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T.A. Crutchley, J.D. Pearce, T.E. Craven, M.S. Edwards, R.H. Dean and
K.J. Hansen
Purpose. This retrospective review describes the use and clinical outcome of
cold perfusion protection during branch renal artery (RA) repair in 77
consecutive patients.
Methods. From July 1987 through November 2006, 874 patients had open
operative RA repair to 1312 kidneys. Seventy-seven patients (62 women, 15
men; mean age, 44  17 years) had branch RA reconstruction using ex vivo
or in situ cold perfusion protection for 78 kidneys. Demographic data and
surgical technique were examined. Blood pressure response and renal func-
tion were estimated. Patency of repair was determined by angiography and
renal duplex ultrasound (RDUS) imaging. Primary RA patency was esti-
mated by life-table methods.
Results. Seventy-eight RAs were repaired using ex vivo (49 kidneys) or in situ
(29 kidneys) cold perfusion protection. Bilateral RA repair was performed in
eightpatients,with13 repairs to solitarykidneys.RAdisease includedaneurysm
(RAA) in 50, fibromusculardysplasia (FMD) in 37, atherosclerosis in 5, andarter-
itis in 2; 16 patients had both FMDandRAA.Hypertensionwas present in 93.5%
(mean blood pressure, 184  35/107  19mmHg;mean of 1.9  1.1 drugs). RA
repair includedbypassusing saphenousvein in 69, hypogastric artery in 3, poly-
tetrafluoroethylene (PTFE) in 2, composite vein/PTFE in 2, cephalic vein in 1, or
aneurysmorrhaphy in 1. The eight bilateral RA repairswere staged. One patient
requiredbilateral coldperfusionprotection.Oneplannednephrectomywasper-
formed at the time of contralateral ex vivo reconstruction. No primary nephrec-
tomies were required for intended reconstruction. Each RA reconstruction
required branch dissection and reconstruction (mean of 2.8  1.6 branches
were repaired). Mean cold ischemia time was 125  40 minutes. Each kidney
was reconstructed in an orthotopic fashion. Five early failures of repair required
threenephrectomies andoneoperative revision. Basedonpostoperative angiog-
raphy or RDUS, or both, primary patency of RA repair at 12 months was
85%  5%; assisted primary patency was 93% 4%. Among patients with pre-
operative hypertension, 15% were cured, 65% were improved, and 20% were
considered failed. Early renal function was improved in 35%, unchanged in
48%, and worse in 17%. Four patients had perioperative acute tubular necrosis.
No patient progressed to dialysis-dependence.
Conclusion. Both ex vivo and in situ cold perfusion protection extend the safe
renal ischemia time for complex branch RA repair and avoid the need for
nephrectomy.
Spinal cord ischemia may be reduced via a novel technique of
intercostal artery revascularization during open thoracoabdominal
aneurysm repair
E.Y. Woo, M. Mcgarvey, B.M. Jackson, J.E. Bavaria, R.M. Fairman and
A. Pochettino
Objective. To describe a novel technique for maximal reimplantation of inter-
costal arteries during thoracoabdominal aortic aneurysm repair.
Methods. Eight patients underwent thoracoabdominal aortic aneurysm
(TAAA) repair with this new technique from 2005 to 2006. Follow-up ranged
from 6 to 14 months. All patients had a previous type B dissection with sub-
sequent aneurysmal degeneration into an extent I TAAA. Aneurysm repair
was performed through a thoracoabdominal incision and circulatory arrest
in seven and left atrial-left femoral (LA-FA) bypass in one. The grafts ex-
tended from the distal arch at the subclavian artery to the visceral and renal
arteries. An 8 mm graft was then extended from the proximal to the distal
graft with a spatulation of the graft allowing a side-to-side anastomosis of
the graft to the posterior aortic wall incorporating multiple pairs of intercostal
arteries. Intraoperative electroencephalogram (EEG) and somatosensory
evoked potentials (SSEP) were monitored during each operation.
Results. All patients were ambulatory at the time of admission. One patient
had suffered a previous spinal cord infarction from the original dissection
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was an average of seven pairs of patent intercostal arteries upon opening
the aorta. We reimplanted an average of five pairs of vessels. There were
no perioperative complications. No patients sustained transient or permanent
paraplegia in the postoperative or follow-up period. The one patient with
preoperative leg weakness had reported subjective increased strength in
the affected leg after the operation. In four cases, normalization of SSEP
waveforms did not occur until after reimplantation of the intercostal arteries
despite full return of EEG waveforms, restoration of lower extremity perfu-
sion, and rewarming of the patient. Follow-up CT scan angiogram demon-
strated that all reconstructions were patent through the follow-up period.
Conclusions. Paraplegia is an extremely morbid complication associated with
TAAA repair. We describe a technique that allows reimplantation of almost
all intercostal arteries as one patch circumventing the need for selective reim-
plantation. Furthermore, our technique ensures continued patency of this
patch graft as the outflow resistance is decreased by creating a continuous
flow loop. Although this is a small case series, we had no incidence of acute
or delayed paraplegia in this high risk group. Our technique of intercostal re-
implantation is applicable to all open TAAA repair at high-risk for paraplegia
and may be an important adjunct in preventing spinal cord ischemia.
Acute aortic dissection associated with use of cocaine
J.C. Daniel, T.T. Huynh, W. Zhou, P. Kougias, H.F. El Sayed, J. Huh,
J.S. Coselli and P.H. Lin
Purpose. Cocaine use can result in a variety of cardiovascular complications,
including myocardial infarction, arterial thrombosis, coronary dissection, and
cardiomyopathy. Cocaine-induced aortic dissection is uncommon and has
been described largely in case reports. The purpose of this study was to
review our experience with aortic dissection associated with cocaine abuse.
Methods. A retrospective chart review was performed of all hospital records
during a 15-year period in patients diagnosed with aortic dissection. Among
the 164 cases of acute aortic dissection, 16 patients (9.8%) had used cocaine or
its derivative, crack cocaine, within 24 hours prior to the onset of symptoms.
The remaining 148 patients (90.2%) had no history of cocaine usage. Clinical
features, management, and outcome in these two groups were compared.
Results. In the cocaine group, powder cocaine was inhaled intranasally in 11
patients (69%) and crack cocaine was smoked in five cases (31%). The mean
duration between cocaine use and the onset of aortic dissection was 12.8
hours (range, 4 to 24 hours). Patients in the cocaine group were younger in
age and more likely to have a history of polysubstance abuse than the non-
cocaine cohort. In the cocaine group, the incidence of DeBakey dissection
type I, II, IIIa, and IIIb was 19%, 25%, 38%, and 19%, respectively. In the
group without cocaine use, the incidence of DeBakey dissection type I, II,
IIIa, and IIIb was 18%, 23%, 39%, and 20%, respectively. Surgical intervention
for aortic dissection was performed in 50% of the cocaine group and 45% of
the non-cocaine group. In patients who underwent surgical repair, greater
pulmonary complications occurred in the cocaine group than the non-cocaine
group (n¼ 0.02). No difference was noted in the hospital length of stay or
30-day operative mortality among the two groups.
Conclusions. Cocaine-associated aortic dissection occurs in predominantly
malepatientswith illicit drugabusewhowere younger thanpatientswith aortic
dissection without cocaine use. Greater pulmonary complications can occur in
patients with cocaine-related aortic dissection following surgical interventions.
Fibrinogen and high-sensitive C-reactive protein as serologic predictors
for perioperative cerebral microembolic lesions after carotid
endarterectomy
P. Heider, H. Poppert, O. Wolf, T. Liebig, J. Pelisek, T. Schuster and
H.H. Eckstein
Background. Neurologic deficit caused by cerebral ischemia defines the out-
come of carotid endarterectomy (CEA). Although few patients have clinicallyAugust 2007  374/376
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375Abstractsevident neurologic deficit, diffusion-weighted imaging (DWI) presents
a number of cases with ischemic brain lesions. This study should elucidate
preoperative risk factors for perioperative microemboli that cause brain
infarction.
Methods. We studied 183 patients (58 women, 69.2 12.7 years; 125 men,
69.3 8.9 years) with high-degree carotid artery stenosis. DWI was per-
formed before and after CEA to analyze new cerebral ischemia. Blood sam-
ples were obtained before operation to measure fibrinogen and C-reactive
protein (CRP), and preoperative high-sensitive CRP (hsCRP) was analyzed
in 30 consecutive patients.
Results. Postoperative DWI revealed new ipsilateral ischemic lesions in 41
patients (22.4%), and eight (4.4%) showed new neurologic deficit. Preopera-
tive fibrinogen levels were higher in patients with new lesions (397.6 mg/
dL 104.7 mg/dL) than in those without (324.7 mg/dL 74.2 mg/dL,
P< .001). Preoperative levels of hsCRP were also higher in patients with
new lesions (7.9 mg/dL 5.2 mg/dL) than in those without (2.8 mg/
dL 2.6 mg/dL, P¼ .004). Significant association was found between fibrin-
ogen and CRP (Spearman r¼ 0.402; P< .001) as well as hsCRP (Spearman
r¼ 0.603, P¼ .003). No association was found between postoperative lesions
and CRP (P¼ .833).
Conclusion. The present study demonstrates that preoperative levels of
fibrinogen and hsCRP are independent determinants for new periprocedural
cerebral ischemic lesions caused by microembolic events. There is still not
sufficient evidence to recommend measurement of CRP as a prognostic
marker for perioperative cerebral lesion.
Duplex scan surveillance after carotid angioplasty and stenting: A
rational definition of stent stenosis
P.A. Armstrong, D.F. Bandyk, B.L. Johnson, M.L. Shames, B.R. Zwiebel and
M.R. Back
Objective. A duplex ultrasound (DUS) surveillance algorithm used after
carotid endarterectomy (CEA) was applied to patients after carotid stenting
and angioplasty (CAS) to determine the incidence of high-grade stent
stenosis, its relationship to clinical symptoms, and the outcome of
reintervention.
Methods. In 111 patients who underwent 114 CAS procedures for symp-
tomatic (n¼ 62) or asymptomatic (n¼ 52) atherosclerotic or recurrent ste-
nosis after CEA involving the internal carotid artery (ICA), DUS
surveillance was performed 30 days and every 6 months thereafter.
High-grade stenosis (peak systolic velocity [PSV] >300 cm/s, diastolic ve-
locity >125 cm/s, internal carotid artery stent/proximal common carotid
artery ratio >4) involving the stented arterial segment prompted diagnostic
angiography and repair when >75% diameter-reduction stenosis was con-
firmed. Criteria for >50% CAS stenosis was a PSV >150 cm/s with a PSV
stent ratio >2.
Results. All 114 carotid stents were patent on initial DUS imaging, including
90 (79%) with PSV <150 cm/s (94  24 cm/s), 23 (20%) with PSV >150 cm/s
(183  34 cm/s), and one with high-grade, residual stenosis (PSV¼ 355).
During subsequent surveillance, 81 CAS sites (71%) exhibited no change
in stenosis severity, nine sites demonstrated stenosis regression to <50%
diameter reduction, and five sites developed velocity spectra of a high-
grade stenosis. Angiography confirmed >75% diameter reduction in all
six CASs with DUS-detected high-grade stenosis, all patients were asymp-
tomatic, and treatment consisted of endovascular (n¼ 5) or surgical
(n¼ 1) repair. During the mean 33-month follow-up period, three patients
experienced ipsilateral, reversible neurologic events at 30, 45, and 120
days after CAS; none was associated with severe stent stenosis. No stent
occlusions occurred, and no patient with >50% CAS stenosis on initial or
subsequent testing developed a permanent ipsilateral permanent neurologic
deficit or stroke-related death.
Conclusion. DUS surveillance after CAS identified a 5% procedural failure
rate due to the development of high-grade in-stent stenosis. Both progression
and regression of stent stenosis severity was observed on serial testing, but
70% of CAS sites demonstrated velocity spectra consistent with <50% dia-
meter reduction. The surveillance algorithm used, including reintervention
for asymptomatic high-grade CAS stenosis, was associated with stent
patency and the absence of disabling stroke.Vascular abnormalities in patients with neurofibromatosis syndrome
type I: Clinical spectrum, management, and results
G.S. Oderich, T.M. Sullivan, T.C. Bower, P. Gloviczki, D.V. Miller, D. Babovic-
Vuksanovic, T.A. Macedo and A. Stanson
Purpose. Neurofibromatosis type I (NF-I) is an autosomal dominant disorder
affecting one in 3000 individuals. Vascular abnormalities are a well-
recognized manifestation of NF-I. The purpose of this study is to review
the spectrum, management, and clinical outcome of patients with vascular
abnormalities and NF-I.
Methods. We retrospectively reviewed 31 patients (15 males, 16 females) with
clinical NF-I and vascular abnormalities identified from imaging or operative
findings between 1976 and 2005.
Results. The diagnosis of NF-I was made at a mean age of 11  10 years with
vascular lesions identified at a mean age of 38  16 years. There were 76 vas-
cular abnormalities, including 38 aneurysms, 20 arterial stenoses, 5 arterio-
venous malformations (AVM), 5 arteries compressed or invaded by neural
tumors, and 6 abnormalities of the heart valves. Arterial lesions were located
in the aorta (n¼ 17) and in the renal (n¼ 12), mesenteric (n¼ 12), carotid-
vertebral (n¼ 10), intracerebral (n¼ 4), and subclavian-axillary and iliofe-
moral arteries (3 each). Interventions were required in 23 patients (74%); 15
underwent 24 arterial reconstructions, including 9 renal, 8 aortic, 4 mesen-
teric, 2 carotid, and 1 femoral. The other eight patients had excision of
AVM in three, vessel ligation in two, and clipping of cerebral aneurysms,
coil embolization of hepatic aneurysms, and left thoracotomy in one patient
each. One patient died of ruptured abdominal aortic aneurysm. Six patients
(26%) had postoperative complications, including pneumonia in two, and
stroke, acalculous cholecystitis, brachial plexopathy and chylothorax in one
patient each. The median follow up was 4.1 years (range, 6 months to 20
years). Late vascular problems developed in three patients, including graft
stenoses in two and rupture of another aortic aneurysm in one. Freedom
from graft-related complications was 83% at 10 years. Patient survival at 10
years was 77%, less than the 86% expected survival for the general popula-
tion (P< .001).
Conclusion. Patients with NF-I have a wide spectrum of vascular abnormal-
ities, most notably aneurysms or stenoses of the aortic, renal, and mesenteric
circulation. Operative treatment of symptomatic patients with vascular
lesions or large aneurysms is safe, effective, and durable.
Platelet activation increases with the severity of peripheral arterial
disease: Implications for clinical management
S. Rajagopalan, I. Mckay, I. Ford, P. Bachoo, M. Greaves and J. Brittenden
Introduction. Patients with peripheral arterial disease (PAD) have increased
mortality from cardiovascular events compared with age and sex matched
controls Platelets play a major role in atherosclerosis and thrombotic vascular
events. Platelet reactivity is increased in patients with PAD compared with
healthy controls. We aimed to determine the relationship, if any, between
platelet activation and severity of disease.
Methods and Results. One hundred eighty-two patients with intermittent
claudication (IC) or subcritical limb ischemia (SLI), defined as the presence
of rest pain or ulceration, had the following investigations performed: plate-
let P-selectin expression and bound fibrinogen by flow cytometric analysis
and platelet aggregation using the rapid platelet function assay with arachi-
donic acid (AA) and thrombin receptor activation peptide (TRAP) as ago-
nists. Patients with SLI compared with IC had significantly enhanced ADP
stimulated P-selectin expression (median 42.45% [inter-quartile range
33.32% to 58.5%] vs 35.2% [26.07% to 46.32%], P¼ .002) and bound fibrinogen
(73.7% [54.3% to 83.2%] vs 63.7% [43.8% to 76.5%], P¼ .001). TRAP stimulated
aggregation was higher (207 [153 to 238] PAU vs 183[155 to 199] PAU, P¼ .04)
but AA mediated aggregation was not significantly different. An ankle-
brachial pressure index (ABPI) of less than 0.6 was associated with increased
ADP stimulated P-selectin and bound fibrinogen (P< .05). ABPI correlated
inversely with ADP stimulated P-selectin expression (r¼0.228, P¼ .003),
ADP stimulated fibrinogen binding (r¼0.156, P¼ .043) and TRAP stimu-
lated aggregation (r¼0.179, P¼ .04).
Conclusion. We have demonstrated for the first time that progression of
severity of PAD is not only reflected by symptoms, signs, and ABPI but
also by increased platelet activity as assessed by both flow cytometry and ag-
gregation. As patients with more severe PAD have increased cardiovascular
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therapy are indicated in these patients.
Short-term and mid-term outcome of isolated symptomatic muscular calf
vein thrombosis
J.-L. Gillet, M.R. Perrin and F.A. Allaert
Background. Although muscular calf vein thrombosis (MCVT) is commonly
seen in everyday practice, no treatment guidelines are available. This study
evaluated short-term and mid-term outcome of isolated symptomatic MCVT.
Method. We included prospectively and consecutively all patients referred to
an outpatient clinic with isolated MCVT. Clinical signs were pain or edema,
or both, of the calf. Diagnosis was established with duplex ultrasound (DUS)
examination. Not completely occlusive and asymptomatic MCVTs were
excluded. Patients were followed up clinically and with DUS at 1, 3, and 9
months, and up to 36 months. Anticoagulant therapy at curative dosage as-
sociated with compression was prescribed for 1 month and was extended
for 2 additional months in case of incomplete recanalization at 1 month or
if risk factors for venous thromboembolism (VTE) were present.
Results. Included were 128 patients (78 women, 50 men) presenting with 131
MCVTs. Their mean age was 57.02  15.36 years (range, 20 to 87 years).Eur J Vasc Endovasc Surg Vol 34, September 2007Thrombus was present in the soleal veins (SoV) in 73 patients (55.7%) and
in the medial gastrocnemius veins (MGV) in 58 (44.3%). Initial symptoms
were isolated pain in the calf in 90 patients, isolated edema of the calf in
six, and pain plus edema in 32. Anticoagulant therapy was prescribed in
53 patients (41.4%) for 1 month, in 59 (46.1%) for 3 months, and in 13
(10.2%) for 6 months. At baseline, nine pulmonary embolisms (7%), compli-
cated with MCVT, were observed in six MGV patients (10.3%) and three SoV
patients (4.1%; P¼ .18). Two nonfatal hemorrhagic events occurred. Three pa-
tients died during the follow-up after anticoagulant therapy had been discon-
tinued. Recanalization of MCVT was considered complete at 1, 3, and 9
months in 54.8%, 84.7%, and 96% of cases, respectively, with no significant
difference between the MGV and the SoV groups. Twenty-nine VTE symp-
tomatic recurrences (PE, n¼ 6; DVT including MCVT, n¼ 23) were observed
in 24 patients (18.8%), with similar figures in both thrombosis groups: none at
3 months, 11 between 3 and 9 months and 18 between 9 and 36 months. No
extension of the MCVT or a recurrence of VTE was observed in patients
treated with anticoagulant therapy. Twelve cases of superficial thrombophle-
bitis occurred during the follow-up period.
Conclusion. This study confirms the place of MCVT in VTE disorders. Pulmo-
nary embolism at the MCVT initial diagnosis was not rare, and mid-term
follow-up (mean, 26.7 months) revealed that 18.8% of patients had at least
one VTE recurrence. The treatment of acute MCVT needs to be standardized
because no guidelines currently exist.
